Should You Buy Johnson & Johnson Before It Splits?
The world's largest healthcare company is about to get a little smaller. Recently, Johnson & Johnson (NYSE: JNJ) told investors it would spin off its consumer health business into a separate new company.
If you've been considering this dividend-paying stock for one reason or another, the impending spinoff isn't anything to worry about. In fact, it makes the stock significantly more attractive. Here's a closer look at the company's plans so you can see why.
Image source: Getty Images.
Source Fool.com
